<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Recash test site | Munksgaard Kloster | Activity</title>
	<link>https://recash.wpsoul.net/members/boatglider40/activity/</link>
	<atom:link href="https://recash.wpsoul.net/members/boatglider40/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Munksgaard Kloster.</description>
	<lastBuildDate>Tue, 28 Jul 2026 11:48:52 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">00fa0caaa73ffe99a0ab3cf8de91cde6</guid>
				<title>Munksgaard Kloster posted an update: A reservoir of replication-competent but latent virus is the [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/136927/</link>
				<pubDate>Thu, 02 Jan 2025 10:36:12 +0000</pubDate>

									<content:encoded><![CDATA[<p>A reservoir of replication-competent but latent virus is the main obstacle to a cure for HIV-1 infection. Much of this reservoir resides in memory CD4 T cells. We hypothesized that these cells can be reactivated with antigens from HIV-1 and other common pathogens to reverse latency.</p>
<p> We obtained mononuclear cells from the peripheral blood&hellip;<span class="activity-read-more" id="activity-read-more-136927"><a href="https://recash.wpsoul.net/activity/p/136927/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d97bed5a0dde157e5e261e4accef2ea4</guid>
				<title>Munksgaard Kloster posted an update: RESULTS After matching patients who had received vedolizumab [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/133943/</link>
				<pubDate>Wed, 01 Jan 2025 10:28:54 +0000</pubDate>

									<content:encoded><![CDATA[<p>RESULTS After matching patients who had received vedolizumab with those who had received adalimumab, the rate of persistence after 3 therapy years was 30.3% for vedolizumab and 27.9% for adalimumab (log-rank p = 0.005). The corresponding figures were 27.8 and 20.8% in the vedolizumab-golimumab matched-pair analysis (log-rank p less then 0.001) and&hellip;<span class="activity-read-more" id="activity-read-more-133943"><a href="https://recash.wpsoul.net/activity/p/133943/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">0599ba4310c266de66ed8dc63811e3ea</guid>
				<title>Munksgaard Kloster posted an update: These and other findings suggest &quot;response&quot; is strongly [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/128204/</link>
				<pubDate>Mon, 30 Dec 2024 10:47:13 +0000</pubDate>

									<content:encoded><![CDATA[<p>These and other findings suggest &#8220;response&#8221; is strongly context dependent, raising questions about the validity of RTI as a means of disability identification.Aim Coronary slow flow (SF) is an important complication of percutaneous coronary intervention (PCI) associated with poor prognosis. The aim was to assess grey-scale intravascular ultrasound&hellip;<span class="activity-read-more" id="activity-read-more-128204"><a href="https://recash.wpsoul.net/activity/p/128204/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">db7aede80d7428d6967ee0c84761a7da</guid>
				<title>Munksgaard Kloster posted an update: Completeness of final reports increased from 39.5% to 45.4% [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/122234/</link>
				<pubDate>Sat, 28 Dec 2024 10:27:06 +0000</pubDate>

									<content:encoded><![CDATA[<p>Completeness of final reports increased from 39.5% to 45.4% (P = .04). The workload for tumor board preparation and discussion did not change significantly. Standardized tumor board reports included 50% (61/122) of the data items carried in the NCR. An automated process was developed to upload information captured in tumor board reports to the NCR&hellip;<span class="activity-read-more" id="activity-read-more-122234"><a href="https://recash.wpsoul.net/activity/p/122234/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">47c9a7433000da427ebb8aecc8b8e36d</guid>
				<title>Munksgaard Kloster posted an update: Background About 5-10% of incidences of breast cancers have [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/116217/</link>
				<pubDate>Thu, 26 Dec 2024 10:42:17 +0000</pubDate>

									<content:encoded><![CDATA[<p>Background About 5-10% of incidences of breast cancers have been reported as a result of germline mutations of BRCA genes. However, the mutational spectrum of BRCA1 and BRCA2 genes among breast cancer Saudi women patients is inadequate at present. Therefore, the present study aimed to report the specific germinal mutation of BRCA1 and BRCA2 in the&hellip;<span class="activity-read-more" id="activity-read-more-116217"><a href="https://recash.wpsoul.net/activity/p/116217/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">fdef35b779af296d20d1b8c4352a0614</guid>
				<title>Munksgaard Kloster became a registered member</title>
				<link>https://recash.wpsoul.net/activity/p/96917/</link>
				<pubDate>Fri, 20 Dec 2024 22:28:28 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>